The TIGIT (Tiragolumab Biosimilar) Monoclonal Antibody (HDbs0026) is a cutting-edge tool for researchers studying T-cell immunoreceptor with Ig and ITIM domains (TIGIT) in immune regulation. This monoclonal antibody, produced through biosimilar technology, provides high specificity and sensitivity for detecting TIGIT in human samples, making it a valuable asset for immunology and oncology studies.TIGIT is a co-inhibitory receptor, known for its role in dampening immune responses and promoting immune tolerance. Its dysregulation has been linked to various diseases, including cancer and autoimmune disorders.
By targeting TIGIT, researchers can gain insights into immune modulation and potentially develop novel therapeutic strategies for combating these diseases.This antibody offers researchers a reliable tool for investigating TIGIT expression and function, particularly in the context of immune checkpoint pathways. Its high reactivity and validation for use in various applications, such as flow cytometry and immunohistochemistry, make it a versatile option for researchers seeking to delve deeper into the intricate mechanisms of immune regulation and potential therapeutic interventions.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
